-The Hindu Every biomedical and health research involving human participants, whether in conventional areas, or in new evolving specialised fields, will have to be conducted in accordance with the provisions of the proposed Biomedical and Health Research Regulation Bill, 2013. Research on human subjects in the specified areas like assisted reproductive technology (ART); organ, tissue and cell therapy; genetic and genomic studies including techniques of genetic engineering and gene therapy; nano medicines;...

-Outlook The Centre today told the Supreme Court that securing Aadhar cards, being issued by Unique Identification Authority of India (UIDAI), was optional and it has not made it mandatory for the citizens. The apex court, hearing a batch of pleas against decisions of some states to make Aadhar cards compulsory for a range of activities including salary, PF disbursals and marriage and property registrations, asked the Centre not to issue it...

-Frontline The government pushes through the Land Acquisition Bill, but critics say it will take away more than what it purports to give. CLOSE on the heels of the passing of the National Food Security Bill, the Congress-led United Progressive Alliance government pushed through its other game-changer initiative, the Right to Fair Compensation and Transparency in Land Acquisition, Rehabilitation and Resettlement Bill, 2013, or LARR Bill, ostensibly to address the injustices...

-Frontline Interview with Jairam Ramesh, Union Minister for Rural Development. THE passage of the Right to Fair Compensation and Transparency in Land Acquisition, Rehabilitation and Resettlement Bill, 2013, is being perceived as a major achievement by the United Progressive Alliance government. The Bill that has replaced the colonial Land Acquisition Act, 1894, went through several changes in order to arrive at a middle path, a term coined by Union Minister for...

-The Business Standard Confusion over clinical trial compensation norms Even as the health ministry is evaluating a formula to compensate victims of clinical trials, an expert committee, headed by Ranjit Roy Chaudhury, has recommended some stringent measures that appear contrary to the formula under consideration. The committee, set up by the ministry to formulate policy and guidelines for clinical trials, has suggested that no compensation be given for therapeutic inefficiency during clinical trials...